Neoplasm Risk in Patients With Rheumatoid Arthritis Treated With Fostamatinib: A Systematic Review and Meta-analysis.

Chen, Yuehong; Liu, Huan; Tian, Yunru; Luo, Zhongling; Yin, Geng; Xie, Qibing

Chen, Yuehong; Liu, Huan; Tian, Yunru; Luo, Zhongling; Yin, Geng; Xie, Qibing.

Afiliação

Chen Y; Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.
Liu H; Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.
Tian Y; Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.
Luo Z; Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.
Yin G; Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.
Xie Q; Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.

Front Pharmacol ; 13: 768980, 2022.

Article em En | MEDLINE | ID: mdl-35308252

Palavras-chave

fostamatinib; meta-analysis; neoplasm; rheumatoid arthritis; systematic review

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies / Systematic_reviews Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google